Combination Osimertinib Plus Selpercatinib For Egfr-Mutant Non-Small Cell Lung Cancer (Nsclc) With Acquired Ret FusionsJ. Rotow,J. Patel,M. Hanley,H. Yu, J. Goldman, H. Nechustan,M. Scheffler, M. Awad, S. Clifford, A. Santucci,L. Silva, R. Tupper,G. Oxnard, J. Kherani,A. DrilonJournal of Thoracic Oncology（2021）引用 21|浏览7暂无评分关键词EGFR-mutant, RET-mutant, NSCLCAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
